Cancer BiologybioRxiv
Tumor Edge-to-Core Transition Promotes Malignancy in Primary-to-Recurrent Glioblastoma Progression in a PLAGL1/CD109-mediated mechanism
C. Li, H. J. Cho, D. Yamashita…·I. Nakano
The paper identifies a CD133down/CD109up signature associated with poor prognosis in glioblastoma recurrence and shows PLAGL1 mediates tumor progression through CD109 regulation.
DOI 10.1093/noajnl/vdaa163